Merck & Co., Inc. (MRK)
150.72
-1.83
(-1.20%)
USD |
NYSE |
Aug 24, 16:00
151.39
+0.67
(+0.44%)
After-Hours: 19:57
Merck Shareholders Equity (Quarterly) : 41.93B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 41.93B |
| March 31, 2026 | 45.88B |
| December 31, 2025 | 52.61B |
| September 30, 2025 | 51.85B |
| June 30, 2025 | 48.99B |
| March 31, 2025 | 48.34B |
| December 31, 2024 | 46.31B |
| September 30, 2024 | 44.50B |
| June 30, 2024 | 43.58B |
| March 31, 2024 | 40.36B |
| December 31, 2023 | 37.58B |
| September 30, 2023 | 41.25B |
| June 30, 2023 | 38.69B |
| March 31, 2023 | 46.83B |
| December 31, 2022 | 45.99B |
| September 30, 2022 | 44.46B |
| June 30, 2022 | 43.24B |
| March 31, 2022 | 40.88B |
| December 31, 2021 | 38.18B |
| September 30, 2021 | 35.79B |
| June 30, 2021 | 33.29B |
| March 31, 2021 | 26.94B |
| December 31, 2020 | 25.32B |
| September 30, 2020 | 29.19B |
| June 30, 2020 | 27.64B |
| Date | Value |
|---|---|
| March 31, 2020 | 26.20B |
| December 31, 2019 | 25.91B |
| September 30, 2019 | 26.84B |
| June 30, 2019 | 27.64B |
| March 31, 2019 | 27.54B |
| December 31, 2018 | 26.70B |
| September 30, 2018 | 32.42B |
| June 30, 2018 | 32.53B |
| March 31, 2018 | 33.67B |
| December 31, 2017 | 34.34B |
| September 30, 2017 | 38.25B |
| June 30, 2017 | 39.46B |
| March 31, 2017 | 39.84B |
| December 31, 2016 | 40.09B |
| September 30, 2016 | 43.74B |
| June 30, 2016 | 43.36B |
| March 31, 2016 | 43.81B |
| December 31, 2015 | 44.68B |
| September 30, 2015 | 45.59B |
| June 30, 2015 | 46.45B |
| March 31, 2015 | 47.76B |
| December 31, 2014 | 48.65B |
| September 30, 2014 | 45.22B |
| June 30, 2014 | 48.36B |
| March 31, 2014 | 49.98B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
| Pfizer Inc. | 85.19B |
| Bristol Myers Squibb Co. | 22.32B |
| Abbott Laboratories | 51.11B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 129.80B |
| Total Liabilities (Quarterly) | 87.82B |
| Debt to Equity Ratio | 1.286 |
| Current Ratio | 1.323 |
| Net Debt Paydown Yield | -1.20% |